162 related articles for article (PubMed ID: 38263839)
1. Gamma delta lymphoma: a pictorial review of F-18 fluorodeoxyglucose PET/CT findings and a brief review of the literature.
Rayamajhi SJ; Ponisio MR; Mehta-Shah N
Br J Radiol; 2024 Jan; 97(1153):41-52. PubMed ID: 38263839
[TBL] [Abstract][Full Text] [Related]
2. The role of
McDonald EO; Amanullah AA; Park PSU; Song W; Werner TJ; Alavi A; Revheim ME
Ann Nucl Med; 2023 Jun; 37(6):328-348. PubMed ID: 37095393
[TBL] [Abstract][Full Text] [Related]
3. Rare hepatosplenic gamma-delta T-cell lymphoma detected by
Lu X; Yang J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(5):335-336. PubMed ID: 36702381
[No Abstract] [Full Text] [Related]
4. PET/CT: Clinical role in lymphomas.
Papathanasiou N
Hell J Nucl Med; 2023; 26 Suppl():36-37. PubMed ID: 37658560
[No Abstract] [Full Text] [Related]
5. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
6. Extensive Cutaneous-Mucosal and Muscular Involvement of Gamma/Delta Cutaneous T-Cell Lymphoma on 18 F-FDG PET/CT.
Peslier H; Reichart J; Boursot C; Cohen-Tannugi K; Lacoeuille F
Clin Nucl Med; 2024 May; 49(5):e206-e207. PubMed ID: 38389221
[TBL] [Abstract][Full Text] [Related]
7.
Li C; He Y
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):649-650. PubMed ID: 32632459
[No Abstract] [Full Text] [Related]
8. Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas.
Spaccarelli N; Gharavi M; Saboury B; Cheng G; Rook AH; Alavi A
Hell J Nucl Med; 2014; 17(2):78-84. PubMed ID: 24997076
[TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma.
Quak E; Salaun V; Le Naoures C; Fruchart C
Clin Nucl Med; 2015 Sep; 40(9):730-1. PubMed ID: 26053728
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC
Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.
Casulo C; Schöder H; Feeney J; Lim R; Maragulia J; Zelenetz AD; Horwitz S
Leuk Lymphoma; 2013 Oct; 54(10):2163-7. PubMed ID: 23369041
[TBL] [Abstract][Full Text] [Related]
14. Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings.
Gong J; Dong A; Wang Y; Zhang X; Yang P; Wang L; Jing W
Medicine (Baltimore); 2016 Apr; 95(17):e3532. PubMed ID: 27124063
[TBL] [Abstract][Full Text] [Related]
15. Utility of
Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK
Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
Qiu L; Tu G; Li J; Chen Y
Nucl Med Commun; 2017 Feb; 38(2):106-116. PubMed ID: 27792043
[TBL] [Abstract][Full Text] [Related]
17. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT in lymphoma.
Juweid ME
Methods Mol Biol; 2011; 727():1-19. PubMed ID: 21331925
[TBL] [Abstract][Full Text] [Related]
19. Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.
Kim YR; Kim SJ; Cheong JW; Kim Y; Jang JE; Cho H; Chung H; Min YH; Yang WI; Cho A; Kim JS
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S245-S252. PubMed ID: 32550718
[TBL] [Abstract][Full Text] [Related]
20. Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.
Dubreuil J; Salles G; Bozzetto J; Tordo J; Djaïleb L; Berriolo-Riedinger A; Leenhardt J; Giammarile F; Meignan M; Skanjeti A
Nucl Med Commun; 2017 Jul; 38(7):563-576. PubMed ID: 28570287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
